Atypical Hemolytic Uremic Syndrome in Tertiary Hospital, Pakistan
Shirin Badruddin* and Salma Rattani
School of Nursing and Midwifery, Aga Khan University, Pakistan
- Corresponding Author:
- Shirin Badruddin
School of Nursing and Midwifery
Aga Khan University, Pakistan
E-mail: [email protected]
Received Date: December 10, 2015; Accepted Date: January 28, 2016 Published Date: February 17, 2016
Citation: Badruddin S, Rattani S (2016) Atypical Hemolytic Uremic Syndrome in Tertiary Hospital, Pakistan. Clinics Mother Child Health 13:229. doi:10.4172/2090-7214.1000229
Copyright: © 2016 Badruddin S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Atypical hemolytic uremic syndrome (HUS) is a rare disorder in children, therefore it may lead to misdiagnosis, delay in treatment, or acute kidney injury. Patients with atypical HUS present signs and symptoms of hemolytic anemia, thrombocytopenia, and higher lactate dehydrogenase and uric acid levels. The main risk factor highlighted is consanguinity, gene mutations, and viral infections. Eculizmab, a humanized anti-C5 monoclonal antibody, has been shown to be an effective treatment modality for such patients. This article will discuss atypical hemolytic uremic syndrome, present case report of a patient suffering with atypical HUS with bad prognosis and poor recovery.